Analysis of the results of the RESTORE-1 Phase 3 trial following its premature termination ... the hospital and at-home settings. InCarda plans to complete the ongoing Phase 1 study, including ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimm ...

“We are thrilled to announce the first two patients were administered TTX-MC138 in our Phase 1 clinical trial. This is a significant milestone for the TTX-MC138 clinical development program with ...

(RTTNews) - Thursday, Pasithea Therapeutics Corp. (KTTA) reported positive initial results from its Phase 1 clinical trial of PAS-004, a new macrocyclic MEK inhibitor aimed at treating ...

“We are excited by the continued advancement of the ELVN-001 Phase 1 trial, and we remain confident in ELVN-001 ... These statements may discuss goals, intentions and expectations as to future plans, ...

Results from the Phase I trial, also the first-in-human study of ... "We are encouraged by the Phase 1 results of mRNA-4359, which demonstrate its potential to elicit strong antigen-specific ...

A team of researchers from City of Hope and The University of Texas M.D. Anderson Cancer Center has reported safety and efficacy results from a Phase 1 trial that ... and team plan to adapt ...

Microsoft Visio for Windows is on sale for its lowest price ever: $17.97. It's an easy way to create flowcharts and diagrams.

(RTTNews) - Monopar Therapeutics Inc. (MNPR), Thursday announced positive early data from its ongoing open-label MNPR-101-Zr Phase 1 trial, confirming the compound's tumor-targeting ability in humans.

Results from the Phase I trial, also the first-in-human study of ... "We are encouraged by the Phase 1 results of mRNA-4359, which demonstrate its potential to elicit strong antigen-specific ...